Medical Procedure News

RSS

MRI referrals determined by loyalty to unit rather than patient choice

Referrers were found to have a strong sense of loyalty to external medical units, with almost eight per cent saying that they had used the same MRI provider for over 25 years. Clinicians, who identified location, staff expertise and scanner quality as key reasons for initially referring patients, said they were difficult to influence thereafter.

26 Apr 2011

New nano-systems capable of binding heparin as effectively as protamine

New nano-systems developed in York may eventually help patients recover from surgery without the danger of allergic reactions to drugs.

26 Apr 2011

FDA clears Sound Surgical's new PowerX Lipo System

Sound Surgical Technologies, a leading manufacturer and distributor of body shaping technologies, announced today that the PowerX Lipo System has been cleared for use by the Food and Drug Administration.

26 Apr 2011

FDA clears Reverse Medical's ReFlex Catheter for neurovascular procedure

Reverse Medical Corporation announced today that it has received US FDA 510k clearance to market the ReFlex line of intracranial catheters for distal neurovascular access and microcatheter therapeutic delivery.

26 Apr 2011

Multipolar electrocoagulation is a safe, effective therapy for Barrett's esophagus

A new study reports that multipolar electrocoagulation in combination with acid suppression is a safe and effective method to ablate nondysplastic Barrett's esophagus over the long term.

26 Apr 2011

Patients of orthopedists are more apt to undergo back surgery

When doctors own or lease MRI equipment, their patients are more likely to receive scans for low back pain. Patients of orthopedists are more apt to undergo back surgery as well, according to a study published online in Health Services Research.

26 Apr 2011

BMY to present belatacept Phase III new data at American Transplant Congress

New data on belatacept, an investigational selective T cell costimulation blocker being studied for use in renal transplantation by Bristol-Myers Squibb Company, will be presented at the American Transplant Congress April 30 - May 4, 2011 in Philadelphia.

26 Apr 2011

SI-BONE receives FDA approval for updated iFuse Implant System

SI-BONE, Inc., a medical device company that is pioneering the use of a minimally invasive surgical device to treat the sacroiliac joint announced the U.S. Food and Drug Administration approved a major modification to the existing product label.

26 Apr 2011

Boston Scientific launches ION Paclitaxel-Eluting Platinum Chromium Coronary Stent System

Boston Scientific Corporation today announced U.S. Food and Drug Administration (FDA) approval and launch of the ION™ Paclitaxel-Eluting Platinum Chromium Coronary Stent System, the Company's third-generation drug-eluting stent technology.

25 Apr 2011

CryoLife's BioGlue Surgical Adhesive launched in Japan

CryoLife, Inc., an implantable biological medical device and cardiovascular tissue processing company, today announced that its BioGlue Surgical Adhesive has launched in Japan and is expected to be available in hospitals by late May 2011.

25 Apr 2011

Nausea and vomiting are most feared of all chemotherapy-related side effects

PediatRx, Inc. today commented on studies which reveal that chemotherapy-induced nausea and vomiting is one of the most feared of all chemotherapy-related side effects. The fear of nausea and subsequent vomiting is many times so significant that patients can develop a condition known as 'anticipatory' nausea, where the patient becomes nauseous primarily as a result of the fear of becoming nauseous.

25 Apr 2011

Enrollment commences in Gore Early TIPS study for ascites at Indiana University Hospital

W. L. Gore & Associates today reported the first patient enrolled in the Gore Early TIPS for Ascites Study. The patient was treated at Indiana University Hospital in Indianapolis, Ind.

25 Apr 2011

Texas Institute for Surgery, StreamVenue partner for innovative endoscopy technology

StreamVenue Healthcare has partnered its "plug and play" products and services with Texas Institute for Surgery At Presbyterian Hospital Dallas to foster innovation in endoscopy technology.

25 Apr 2011

STAA receives CE Mark approval for Visian Implantable Collamer Lens V4 design

STAAR Surgical Company, the leading developer, manufacturer and marketer of minimally invasive ophthalmic lenses for refractive surgery, today announced CE Mark approval for its Visian Implantable Collamer Lens V4c design.

25 Apr 2011

UCI anesthesiologist to use $3.2 million NIH grant for P-TIPS program

A UC Irvine anesthesiologist will use a $3.2 million National Institutes of Health grant to launch a research effort aimed at lessening the anxiety and pain children feel before and after surgery.

25 Apr 2011

ASPO to honor pediatric otolaryngologists at annual meeting in Chicago

The American Society of Pediatric Otolaryngology will recognize the outstanding achievements of researchers in the field of pediatric otolaryngology during their annual meeting, April 29 - May 1, 2011, in Chicago, IL.

25 Apr 2011

Symposium to explore energy balance in physiologically maladaptive Homo sapiens

In the human body, an incessant competition is raging between energy storing-anabolic-processes and the less abundant energy using-catabolic-processes. In most people, energy balance varies within a narrow range.

25 Apr 2011

Pediatric otolaryngologist to earn Charles Ferguson Clinical Science recognition

Stephen Maturo, MD, of Boston, MA, will receive the first place Charles Ferguson Clinical Science Award for outstanding achievement in the field of pediatric otolaryngology for his research paper titled "Intraoperative Laryngeal Electromyography in Children with Vocal Fold Mobility: Results of a Multicenter Longitudinal Study," during their annual meeting, April 29 - May 1, 2011, in Chicago, IL.

25 Apr 2011

JVIR articles highlight SIR's commitment to patient safety in medical imaging

The Society of Interventional Radiology has a long-term commitment to radiation safety, taking a leading role in measuring and assessing radiation dosage; developing educational programs on radiation safety, radiation protection and reduction of skin dosage; and promoting the safety of patients and health care professionals.

22 Apr 2011

Roswell Park Cancer Institute named Blue Distinction Center for Transplants

Roswell Park Cancer Institute (RPCI) has been named a Blue Distinction Center for Transplants® by BlueCross BlueShield of Western New York for demonstrating better overall quality of care and patient results in bone marrow/stem cell (autologous and allogeneic) procedures.

22 Apr 2011